Amount Raised
$20 Million
Round Type
Series E
BoxboroughInformation TechnologyBiotechnologyDescription
RedShift BioAnalytics Inc. (RedShiftBioR), a company providing next-generation platform technology enabling measurement of previously undetectable structure changes in biomolecules, announced today the closing of its Series E Preferred Stock financing. The $20 million financing was led by Illumina Ventures and joined by all of the company’s current major investors, including Technology Venture Partners and Waters Corporation. Proceeds of the financing will be used to fund additional commercial expansion, continued technology innovation, and execution of its product development objectives.
Quick answer
RedShift BioAnalytics raised $20 Million in a Series E round, dated October 18, 2021. RedShift BioAnalytics is based in Boxborough, Massachusetts, United States.
- How much did RedShift BioAnalytics raise?
- RedShift BioAnalytics raised $20 Million in a Series E round on October 18, 2021.
- What does RedShift BioAnalytics do?
- RedShiftBio is redefining the analysis of protein, mabs, peptides, RNA, and LNP structure and concentration.
- Where is RedShift BioAnalytics based and how big is it?
- RedShift BioAnalytics is based in Boxborough, Massachusetts, United States. Fundz records about 30 employees.
- Who are the decision-makers at RedShift BioAnalytics?
- Fundz holds 2 contacts at RedShift BioAnalytics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as RedShift BioAnalytics that raised within 45 days of this round, from Fundz verified event records.
- Avivomed raised $32M (Series A) on December 2, 2021.
- Cambrian BioPharma raised $92M on December 2, 2021.
- Amarna Therapeutics raised $5.4M (Funding Round) on December 1, 2021.
- MedinCell raised $4.3M (Seed) on December 1, 2021.
- Trefoil Therapeutics raised $28M (Series A) on December 1, 2021.
- medimaps group S.A raised $20M (Funding Round) on December 1, 2021.
Who to call at RedShift BioAnalytics, and when
A new round usually means RedShift BioAnalytics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RedShift BioAnalytics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RedShift BioAnalytics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RedShift BioAnalytics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RedShift BioAnalytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
RedShift BioAnalytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.